Used in organic synthesis as an intermediate for pharmaceuticals, particularly in the development of central nervous system agents. Shows potential in the preparation of compounds with antidepressant and stimulant properties. Employed in research settings to study monoaminergic activity due to its structural similarity to known norepinephrine and dopamine reuptake inhibitors. Also utilized in the synthesis of labeled analogs for metabolic and pharmacokinetic studies.